These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 380476)

  • 1. [Role of possible endotoxin contaminants present in some preparations of biological products and injectable drugs].
    Fumarola D
    Ann Sclavo; 1978; 20(4):546-57. PubMed ID: 380476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Verification of contamination with bacterial endotoxins in blood derivatives used in coagulative disorders: observations with the Limulus test].
    Fumarola D; Marcuccio L; Monno R; Panaro A; Longo-Papadia L; Papadia J
    G Batteriol Virol Immunol; 1976; 69(7-12):260-4. PubMed ID: 1028648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [LAL (Limulus Amoebocyte Lysate) test as applied to the safety evaluation of biological preparations].
    Aleksandrowicz J; Kudelski Z
    Rocz Panstw Zakl Hig; 1997; 48(3):275-82. PubMed ID: 9432705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limulus test, parenteral drugs and biological products: an approach.
    Fumarola D; Jirillo E
    G Batteriol Virol Immunol; 1976; 69(1-6):34-8. PubMed ID: 1024849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limulus test, parenteral drugs and biological products: an approach.
    Fumarola D; Jirillo E
    Dev Biol Stand; 1977; 34():97-100. PubMed ID: 838154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods of endotoxin removal from biological preparations: a review.
    Magalhães PO; Lopes AM; Mazzola PG; Rangel-Yagui C; Penna TC; Pessoa A
    J Pharm Pharm Sci; 2007; 10(3):388-404. PubMed ID: 17727802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limulus test, parenteral drugs and biological products: an approach.
    Fumarola D; Jirillo E
    Boll Ist Sieroter Milan; 1976; 55(5):460-1. PubMed ID: 1016596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of bacterial endotoxin in antitumor agents.
    Siegel SE; Nachum R; Leimbrock S; Karon M
    Cancer Treat Rep; 1976 Jan; 60(1):9-15. PubMed ID: 793713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endotoxic contamination of biological products (ribosomal vaccines, viral vaccines and interferon)].
    Fumarola D; Panaro A; Palma R; Mazzone A
    G Batteriol Virol Immunol; 1979; 72(1-6):72-7. PubMed ID: 95449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible contamination of preparation of transfer factor with bacterial endotoxins].
    Fumarola D; Panaro A; Longo-Papadia L; Papadia J
    G Batteriol Virol Immunol; 1976; 69(7-12):229-33. PubMed ID: 1028644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory effects of endotoxin-like contaminants in commonly used protein preparations.
    Bito LZ
    Science; 1977 Apr; 196(4285):83-5. PubMed ID: 557238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endotoxin detection and elimination in biotechnology.
    Sharma SK
    Biotechnol Appl Biochem; 1986 Feb; 8(1):5-22. PubMed ID: 3548752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays.
    Neun BW; Dobrovolskaia MA
    Methods Mol Biol; 2011; 697():121-30. PubMed ID: 21116960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriocins as cytotoxic agents in experimental neoplasms: considerations on the role of possible contaminants].
    Fumarola D; Bello P; Palma R; Miragliotta G; Panaro A
    G Batteriol Virol Immunol; 1977; 70(1-6):87-93. PubMed ID: 614148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current technologies to endotoxin detection and removal for biopharmaceutical purification.
    Schneier M; Razdan S; Miller AM; Briceno ME; Barua S
    Biotechnol Bioeng; 2020 Aug; 117(8):2588-2609. PubMed ID: 32333387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of endotoxin in biological products by the limulus test.
    Cooper JF; Pearson SM
    Dev Biol Stand; 1977; 34():7-13. PubMed ID: 838151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicability of bacterial endotoxins test to various blood products by the use of endotoxin-specific lysates.
    Ochiai M; Yamamoto A; Naito S; Maeyama J; Masumi A; Hamaguchi I; Horiuchi Y; Yamaguchi K
    Biologicals; 2010 Nov; 38(6):629-36. PubMed ID: 20702107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin removal and prevention for pre-clinical biologics production.
    Serdakowski London A; Kerins B; Tschantz WR; Eisfeld J; Mackay K
    Biotechnol J; 2012 Dec; 7(12):1509-16. PubMed ID: 23081824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limulus test, parenteral drugs and biological products: an approach.
    Fumarola D; Jirillo E
    Pathologica; 1977; 69(987-988):59-63. PubMed ID: 325482
    [No Abstract]   [Full Text] [Related]  

  • 20. Guideline for validation of the LAL test as an end-product endotoxin test for human and biological drug products.
    Munson TE
    Prog Clin Biol Res; 1985; 189():211-20. PubMed ID: 4048205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.